30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Cerus Corp (CERS)

Track

Over the last 90 days, Cerus Corp has seen significant insider selling activity, with a total sell value exceeding $1.9 million. Notably, the CEO, CFO, COO, and a Director have engaged in multiple planned and proposed sales. This activity occurred despite a positive 75% earnings surprise in the last reported quarter and a substantial 51.8% stock price increase over the past 90 days.
Stock chart
Ticker: CERS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BJERKHOLT ERIC
1 sale — total 100,000 USD
Sale 9 Jun 2026
Value US$4,305,118.53 | Price 81.90 | Shares 56,944
Proposed sale 9 Jun 2026
Value US$3,345,546.04 | Price 256.35 | Shares 73,403
Proposed sale 9 Jun 2026
Value US$3,384,366.67 | Price 249.38 | Shares 12,418
Planned sale 29 May 2026
Value US$100,000.00 | Price 3.00 | Shares 1,000
Proposed sale 29 May 2026
Value US$50,001.00 | Price 3.00 | Shares 16,667
Planned sale 1 May 2026
Value US$50,001.00 | Price 3.00 | Shares 16,667
Proposed sale 1 May 2026
Value US$50,001.00 | Price 3.00 | Shares 16,667
Proposed sale 1 May 2026
Value US$214,626.68 | Price 2.82 | Shares 76,209
Planned sale 12 Mar 2026
Value US$273,769.44 | Price 1.66 | Shares 165,200
Planned sale 12 Mar 2026
Value US$742,022.90 | Price 1.66 | Shares 447,757
Planned sale 12 Mar 2026
Value US$211,365.92 | Price 1.66 | Shares 127,544
Planned sale 12 Mar 2026
Value US$168,603.53 | Price 1.66 | Shares 101,740
Sale 9 Mar 2026
Value US$76,029.18 | Price 1.88 | Shares 40,426
Proposed sale 9 Mar 2026
Value US$76,029.18 | Price 1.88 | Shares 40,426
Planned sale 6 Mar 2026
Value US$156,804.03 | Price 2.01 | Shares 78,187
Planned sale 6 Mar 2026
Value US$48,603.29 | Price 2.01 | Shares 24,235
Planned sale 6 Mar 2026
Value US$61,859.65 | Price 2.01 | Shares 30,845
Planned sale 6 Mar 2026
Value US$55,744.88 | Price 2.01 | Shares 27,796
Planned sale 6 Mar 2026
Value US$68,375.52 | Price 2.01 | Shares 34,094
Sale 5 Mar 2026
Value US$126,305.31 | Price 2.06 | Shares 61,233
Planned sale 5 Mar 2026
Value US$113,901.56 | Price 2.06 | Shares 55,225
Proposed sale 5 Mar 2026
Value US$113,901.56 | Price 2.06 | Shares 55,225
Proposed sale 5 Mar 2026
Value US$126,299.19 | Price 2.06 | Shares 61,233
Sale 24 Nov 2025
Value US$93,500.00 | Price 1.70 | Shares 55,000
Proposed sale 24 Nov 2025
Value US$93,500.00 | Price 1.70 | Shares 55,000
Buy 25 Aug 2025
Value US$31,250.00 | Price 1.25 | Shares 25,000
Planned sale 14 Mar 2025
Value US$43,608.75 | Price 1.45 | Shares 30,075
Planned sale 14 Mar 2025
Value US$66,705.80 | Price 1.45 | Shares 46,004
Planned sale 14 Mar 2025
Value US$178,099.15 | Price 1.45 | Shares 122,827
Planned sale 14 Mar 2025
Value US$43,608.75 | Price 1.45 | Shares 30,075
Planned sale 14 Mar 2025
Value US$53,273.00 | Price 1.45 | Shares 36,740
Planned sale 13 Mar 2025
Value US$27,476.05 | Price 1.45 | Shares 18,949
Planned sale 13 Mar 2025
Value US$43,478.25 | Price 1.45 | Shares 29,985
Planned sale 13 Mar 2025
Value US$103,074.70 | Price 1.45 | Shares 71,086
Planned sale 13 Mar 2025
Value US$27,476.05 | Price 1.45 | Shares 18,949
Planned sale 13 Mar 2025
Value US$33,563.15 | Price 1.45 | Shares 23,147
Planned sale 12 Mar 2025
Value US$187,276.86 | Price 1.66 | Shares 113,008
Planned sale 7 Mar 2025
Value US$91,354.03 | Price 1.50 | Shares 60,984
Planned sale 7 Mar 2025
Value US$39,156.22 | Price 1.50 | Shares 26,139
Planned sale 7 Mar 2025
Value US$46,659.70 | Price 1.50 | Shares 31,148
Planned sale 7 Mar 2025
Value US$41,130.59 | Price 1.50 | Shares 27,457
Planned sale 7 Mar 2025
Value US$50,930.50 | Price 1.50 | Shares 33,999
Sale 4 Mar 2025
Value US$95,142.00 | Price 1.59 | Shares 60,000
Planned sale 4 Mar 2025
Value US$9,743.16 | Price 1.55 | Shares 6,292
Proposed sale 4 Mar 2025
Value US$90,000.00 | Price 1.50 | Shares 60,000
Planned sale 4 Mar 2025
Value US$16,692.83 | Price 1.55 | Shares 10,780
Planned sale 4 Mar 2025
Value US$9,743.16 | Price 1.55 | Shares 6,292
Planned sale 4 Mar 2025
Value US$12,985.72 | Price 1.55 | Shares 8,386
Planned sale 4 Mar 2025
Value US$35,651.12 | Price 1.55 | Shares 23,023
Planned sale 3 Mar 2025
Value US$80,827.56 | Price 1.58 | Shares 51,254
Planned sale 3 Mar 2025
Value US$95,672.71 | Price 1.58 | Shares 60,656
Proposed sale 3 Mar 2025
Value US$80,822.43 | Price 1.58 | Shares 51,254
Proposed sale 3 Mar 2025
Value US$95,645.85 | Price 1.58 | Shares 60,656
Proposed sale 16 Dec 2024
Value US$28,625.57 | Price 1.72 | Shares 16,667
Planned sale 16 Dec 2024
Value US$28,500.57 | Price 1.71 | Shares 16,667
Buy 13 Dec 2024
Value US$2,932.50 | Price 1.70 | Shares 1,725
Sale 12 Dec 2024
Value US$35,700.00 | Price 1.79 | Shares 20,000
Proposed sale 12 Dec 2024
Value US$35,700.00 | Price 1.79 | Shares 20,000
Planned sale 4 Sep 2024
Value US$116,825.91 | Price 2.15 | Shares 54,272
Proposed sale 4 Sep 2024
Value US$116,825.91 | Price 2.15 | Shares 54,272
Planned sale 3 Sep 2024
Value US$61,919.04 | Price 2.18 | Shares 28,385
Proposed sale 3 Sep 2024
Value US$61,919.04 | Price 2.18 | Shares 28,385
Planned sale 15 Aug 2024
Value US$34,417.35 | Price 2.07 | Shares 16,667
Proposed sale 15 Aug 2024
Value US$34,427.36 | Price 2.07 | Shares 16,667
Planned sale 2 Aug 2024
Value US$54,012.50 | Price 2.50 | Shares 21,605
Proposed sale 2 Aug 2024
Value US$54,012.50 | Price 2.50 | Shares 21,605
Buy 13 May 2024
Value US$4,974.75 | Price 1.99 | Shares 2,500
Buy 10 May 2024
Value US$3,578.20 | Price 1.79 | Shares 2,000
Buy 9 May 2024
Value US$37,800.00 | Price 1.89 | Shares 20,000
Buy 9 May 2024
Value US$4,688.75 | Price 1.88 | Shares 2,500
Planned sale 14 Mar 2024
Value US$28,352.38 | Price 1.97 | Shares 14,360
Planned sale 14 Mar 2024
Value US$35,191.71 | Price 1.97 | Shares 17,824
Planned sale 14 Mar 2024
Value US$128,195.25 | Price 2.02 | Shares 63,611
Planned sale 14 Mar 2024
Value US$42,443.68 | Price 1.97 | Shares 21,497
Planned sale 14 Mar 2024
Value US$52,902.07 | Price 1.97 | Shares 26,794
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-11 2026-06-09 S Sale
3.3
BJERKHOLT ERIC
Non-Executive Director
56,944 -24.6%
81.90
US$4,305,119 		56,944 -24.6% 81.90 US$4,305,119
2026-06-09 2026-06-09 PrS Proposed sale
3.3
ERIC BJERKHOLT

Director

Non-Executive Director
73,403
256.35
US$3,345,546 		73,403 256.35 US$3,345,546
2026-06-09 2026-06-09 PrS Proposed sale
3.3
ERIC BJERKHOLT

Director

Non-Executive Director
12,418
249.38
US$3,384,367 		12,418 249.38 US$3,384,367
2026-06-02 2026-05-29 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
1,000 -1.0%
3.00
US$100,000 		1,000 -1.0% 3.00 US$100,000
2026-05-29 2026-05-29 PrS Proposed sale
2.2
VIVEK K JAYARAMAN

Officer

Officer
16,667
3.00
US$50,001 		16,667 3.00 US$50,001
2026-05-05 2026-05-01 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
16,667 -1.0%
3.00
US$50,001 		16,667 -1.0% 3.00 US$50,001
2026-05-01 2026-05-01 PrS Proposed sale
2.2
VIVEK K JAYARAMAN

Officer

Officer
16,667
3.00
US$50,001 		16,667 3.00 US$50,001
2026-05-01 2026-05-01 PrS Proposed sale
2.8
RICHARD J BENJAMIN

Officer

Officer
76,209
2.82
US$214,627 		76,209 2.82 US$214,627
2026-03-16 2026-03-12 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
165,200 -8.6%
1.66
US$273,769 		165,200 -8.6% 1.66 US$273,769
2026-03-16 2026-03-12 PlS Planned sale
2.8
Greenman William Mariner

President and CEO

Executive Director
447,757 -8.2%
1.66
US$742,023 		447,757 -8.2% 1.66 US$742,023
2026-03-16 2026-03-12 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
127,544 -10.9%
1.66
US$211,366 		127,544 -10.9% 1.66 US$211,366
2026-03-16 2026-03-12 PlS Planned sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
101,740 -11.6%
1.66
US$168,604 		101,740 -11.6% 1.66 US$168,604
2026-03-09 2026-03-09 S Sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
40,426 -4.4%
1.88
US$76,029 		40,426 -4.4% 1.88 US$76,029
2026-03-09 2026-03-09 PrS Proposed sale
2.8
RICHARD J BENJAMIN

Officer

Officer
40,426
1.88
US$76,029 		40,426 1.88 US$76,029
2026-03-09 2026-03-06 PlS Planned sale
2.8
Greenman William Mariner

President and CEO

Executive Director
78,187 -1.4%
2.01
US$156,804 		78,187 -1.4% 2.01 US$156,804
2026-03-09 2026-03-06 PlS Planned sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
24,235 -2.6%
2.01
US$48,603 		24,235 -2.6% 2.01 US$48,603
2026-03-09 2026-03-06 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
30,845 -2.8%
2.01
US$61,860 		30,845 -2.8% 2.01 US$61,860
2026-03-09 2026-03-06 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
27,796 -2.3%
2.01
US$55,745 		27,796 -2.3% 2.01 US$55,745
2026-03-09 2026-03-06 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
34,094 -1.8%
2.01
US$68,376 		34,094 -1.8% 2.01 US$68,376
2026-03-09 2026-03-05 S Sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
61,233 -6.1%
2.06
US$126,305 		61,233 -6.1% 2.06 US$126,305
2026-03-09 2026-03-05 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
55,225 -4.4%
2.06
US$113,902 		55,225 -4.4% 2.06 US$113,902
2026-03-05 2026-03-05 PrS Proposed sale
2.8
KEVIN D GREEN

Officer

Officer
55,225
2.06
US$113,902 		55,225 2.06 US$113,902
2026-03-05 2026-03-05 PrS Proposed sale
2.8
RICHARD J BENJAMIN

Officer

Officer
61,233
2.06
US$126,299 		61,233 2.06 US$126,299
2025-11-26 2025-11-24 S Sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
55,000 -7.0%
1.70
US$93,500 		55,000 -7.0% 1.70 US$93,500
2025-11-24 2025-11-24 PrS Proposed sale
2.7
CHRYSTAL NIKOLE JENSEN

Officer

Officer
55,000
1.70
US$93,500 		55,000 1.70 US$93,500
2025-08-25 2025-08-25 B Purchase
3.5
Gregory Dean A.
Non-Executive Director
25,000 +40.5%
1.25
US$31,250 		25,000 +40.5% 1.25 US$31,250
2025-03-17 2025-03-14 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
30,075 -3.7%
1.45
US$43,609 		30,075 -3.7% 1.45 US$43,609
2025-03-17 2025-03-14 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
46,004 -3.1%
1.45
US$66,706 		46,004 -3.1% 1.45 US$66,706
2025-03-17 2025-03-14 PlS Planned sale
2.8
Greenman William Mariner

President and CEO

Executive Director
122,827 -2.9%
1.45
US$178,099 		122,827 -2.9% 1.45 US$178,099
2025-03-17 2025-03-14 PlS Planned sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
30,075 -4.2%
1.45
US$43,609 		30,075 -4.2% 1.45 US$43,609
2025-03-17 2025-03-14 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
36,740 -4.0%
1.45
US$53,273 		36,740 -4.0% 1.45 US$53,273
2025-03-17 2025-03-13 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
18,949 -2.3%
1.45
US$27,476 		18,949 -2.3% 1.45 US$27,476
2025-03-17 2025-03-13 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
29,985 -2.0%
1.45
US$43,478 		29,985 -2.0% 1.45 US$43,478
2025-03-17 2025-03-13 PlS Planned sale
2.8
Greenman William Mariner

President and CEO

Executive Director
71,086 -1.6%
1.45
US$103,075 		71,086 -1.6% 1.45 US$103,075
2025-03-17 2025-03-13 PlS Planned sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
18,949 -2.6%
1.45
US$27,476 		18,949 -2.6% 1.45 US$27,476
2025-03-17 2025-03-13 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
23,147 -2.5%
1.45
US$33,563 		23,147 -2.5% 1.45 US$33,563
2026-03-16 2025-03-12 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
113,008 -10.7%
1.66
US$187,277 		113,008 -10.7% 1.66 US$187,277
2025-03-10 2025-03-07 PlS Planned sale
2.8
Greenman William Mariner

President and CEO

Executive Director
60,984 -1.4%
1.50
US$91,354 		60,984 -1.4% 1.50 US$91,354
2025-03-10 2025-03-07 PlS Planned sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
26,139 -3.4%
1.50
US$39,156 		26,139 -3.4% 1.50 US$39,156
2025-03-10 2025-03-07 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
31,148 -3.2%
1.50
US$46,660 		31,148 -3.2% 1.50 US$46,660
2025-03-10 2025-03-07 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
27,457 -3.2%
1.50
US$41,131 		27,457 -3.2% 1.50 US$41,131
2025-03-10 2025-03-07 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
33,999 -2.2%
1.50
US$50,931 		33,999 -2.2% 1.50 US$50,931
2025-03-05 2025-03-04 S Sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
60,000 -12.9%
1.59
US$95,142 		60,000 -12.9% 1.59 US$95,142
2025-03-05 2025-03-04 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
6,292 -1.3%
1.55
US$9,743 		6,292 -1.3% 1.55 US$9,743
2025-03-05 2025-03-04 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
10,780 -1.2%
1.55
US$16,693 		10,780 -1.2% 1.55 US$16,693
2025-03-05 2025-03-04 PlS Planned sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
6,292 -1.6%
1.55
US$9,743 		6,292 -1.6% 1.55 US$9,743
2025-03-05 2025-03-04 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
8,386 -1.5%
1.55
US$12,986 		8,386 -1.5% 1.55 US$12,986
2025-03-05 2025-03-04 PlS Planned sale
2.8
Greenman William Mariner

President and CEO

Executive Director
23,023 -0.7%
1.55
US$35,651 		23,023 -0.7% 1.55 US$35,651
2025-03-04 2025-03-04 PrS Proposed sale
2.7
Jensen Chrystal

Officer

Officer
60,000
1.50
US$90,000 		60,000 1.50 US$90,000
2025-03-05 2025-03-03 PlS Planned sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
51,254 -11.3%
1.58
US$80,828 		51,254 -11.3% 1.58 US$80,828
2025-03-05 2025-03-03 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
60,656 -10.9%
1.58
US$95,673 		60,656 -10.9% 1.58 US$95,673
2025-03-03 2025-03-03 PrS Proposed sale
2.8
RICHARD J BENJAMIN

Officer

Officer
51,254
1.58
US$80,822 		51,254 1.58 US$80,822
2025-03-03 2025-03-03 PrS Proposed sale
2.8
KEVIN D GREEN

Officer

Officer
60,656
1.58
US$95,646 		60,656 1.58 US$95,646
2024-12-16 2024-12-16 PrS Proposed sale
2.7
CHRYSTAL NIKOLE JENSEN

Officer

Officer
16,667
1.72
US$28,626 		16,667 1.72 US$28,626
2024-12-16 2024-12-16 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
16,667 -3.5%
1.71
US$28,501 		16,667 -3.5% 1.71 US$28,501
2025-01-02 2024-12-13 B Purchase
3.5
Gregory Dean A.
Non-Executive Director
1,725 +2.9%
1.70
US$2,932 		1,725 +2.9% 1.70 US$2,932
2024-12-16 2024-12-12 S Sale
3.3
BJERKHOLT ERIC
Non-Executive Director
20,000 -11.0%
1.79
US$35,700 		20,000 -11.0% 1.79 US$35,700
2024-12-12 2024-12-12 PrS Proposed sale
3.3
BJERKHOLT ERIC

Director

Non-Executive Director
20,000
1.79
US$35,700 		20,000 1.79 US$35,700
2024-09-05 2024-09-04 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
54,272 -9.2%
2.15
US$116,826 		54,272 -9.2% 2.15 US$116,826
2024-09-04 2024-09-04 PrS Proposed sale
2.8
KEVIN D GREEN

Officer

Officer
54,272
2.15
US$116,826 		54,272 2.15 US$116,826
2024-09-05 2024-09-03 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
28,385 -4.6%
2.18
US$61,919 		28,385 -4.6% 2.18 US$61,919
2024-09-03 2024-09-03 PrS Proposed sale
2.8
KEVIN D GREEN

Officer

Officer
28,385
2.18
US$61,919 		28,385 2.18 US$61,919
2024-08-19 2024-08-15 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
16,667 -3.4%
2.07
US$34,417 		16,667 -3.4% 2.07 US$34,417
2024-08-15 2024-08-15 PrS Proposed sale
2.7
CHRYSTAL NIKOLE JENSEN

Officer

Officer
16,667
2.07
US$34,427 		16,667 2.07 US$34,427
2024-08-07 2024-08-02 PlS Planned sale
2.8
Benjamin Richard J

Chief Medical Officer

Officer
21,605 -4.7%
2.50
US$54,012 		21,605 -4.7% 2.50 US$54,012
2024-08-02 2024-08-02 PrS Proposed sale
2.8
RICHARD J BENJAMIN

Officer

Officer
21,605
2.50
US$54,012 		21,605 2.50 US$54,012
2024-05-14 2024-05-13 B Purchase
2.0
Shan Hua
Non-Executive Director
2,500 +8.4%
1.99
US$4,975 		2,500 +8.4% 1.99 US$4,975
2024-05-13 2024-05-10 B Purchase
3.7
NACHTSHEIM JAMI K
Non-Executive Director
2,000 +1.9%
1.79
US$3,578 		2,000 +1.9% 1.79 US$3,578
2024-05-10 2024-05-09 B Purchase
3.7
Witney Frank
Non-Executive Director
20,000 +12.5%
1.89
US$37,800 		20,000 +12.5% 1.89 US$37,800
2024-05-09 2024-05-09 B Purchase
3.3
Swisher Daniel N JR
Non-Executive Director
2,500 +2.4%
1.88
US$4,689 		2,500 +2.4% 1.88 US$4,689
2024-03-14 2024-03-14 PlS Planned sale
CORASH LAURENCE M

Chief Scientific Officer

Officer
14,360 -0.6%
1.97
US$28,352 		14,360 -0.6% 1.97 US$28,352
2024-03-14 2024-03-14 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
17,824 -3.5%
1.97
US$35,192 		17,824 -3.5% 1.97 US$35,192
2024-03-14 2024-03-14 PlS Planned sale
2.8
Greenman William Mariner

President and CEO

Executive Director
63,611 -2.0%
2.02
US$128,195 		63,611 -2.0% 2.02 US$128,195
2024-03-14 2024-03-14 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
21,497 -3.4%
1.97
US$42,444 		21,497 -3.4% 1.97 US$42,444
2024-03-14 2024-03-14 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
26,794 -3.0%
1.97
US$52,902 		26,794 -3.0% 1.97 US$52,902
Explore more

More insider trading research around Cerus Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America